Evidence map›Paper›PMID 39605011›Full record

ArticleBMC proceedings2024

World Health Organization African Region national heads of units of diagnostics and laboratory services meetings proceedings.

Sheick Oumar Coulibaly, Michelle Amri, Christine Vuguziga, Aminata Binetou-Wahebine Seydi, Lorna Maria Aine, Bertha Kembabazi, Sokona Sy, Lindiwe Elizabeth Makubalo

Abstract read
In one paragraph

Article in BMC proceedings, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sheick Oumar CoulibalyWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo. coulibalysh@who.int.
Michelle AmriThe W. Maurice Young Centre for Applied Ethics, School of Population and Public Health, University of British Columbia, 2206 East Mall, Vancouver, BC, V6T 1Z3, Canada.ORCID https://orcid.org/0000-0001-6692-3340
Christine VuguzigaWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo.
Aminata Binetou-Wahebine SeydiWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo.
Lorna Maria AineWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo.
Bertha KembabaziWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo.
Sokona SyWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo.
Lindiwe Elizabeth MakubaloWHO Regional Office for Africa, Office of the Assistant Regional Director, Cité du Djoué, Brazzaville, PB06, Republic of the Congo.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIn the World Health Organization (WHO) African Region, many cases of serious and preventable diseases remain unmanaged because appropriate and good quality diagnostic support is not available at all levels within countries' health systems. Diagnostic and laboratory services influence the efficiency and effectiveness of both clinical and public health functions, including diagnosis, treatment, health promotion, disease prevention, surveillance and response, and research. Essential to global health security, these services are vital to decision-making processes by clinicians, epidemiologists, public health specialists, and health policymakers. To update, promote, and reinforce diagnostic and laboratory services, it was deemed necessary to organize consultation meetings. These consultation meetings hosted: national diagnostic and laboratory directors or heads of units within ministries of health; officers in charge of laboratories from WHO country offices; representatives of the WHO African Regional Office (AFRO) clusters, units, and Headquarters; experts; and strategic partners. This article details the consultation meetings hosted in Lomé, Togo from 14 to 17 June 2022 and in Kigali, Rwanda from 5 to 7 July 2022.

methodsAlthough the two meetings were made distinct due to their different operating languages-French and English, respectively-each consultative meeting sought to engage participants in the same thematic areas of discussion, thus containing the same presentations and areas of discussion. This article compiles the presentations of both meetings, where a total of 85 individuals attended, reflecting 30 countries in the African Region.

resultsSummaries of technical presentations at both meetings are provided, which have the following titles: (1) "AFRO: new vision for the laboratory sector;" (2) "WHO strategies for strengthening laboratories;" (3) "Collaborative registration process for in vitro diagnostic products: introduction and implementation;" (4) "Status of diagnostics and laboratory regulations in the African Region;" (5) "Health technology management;" (6) "The Global Laboratory Leadership Programme;" (7) "Model list of essential in vitro diagnostic devices;" (8) "Primary health care & laboratory and diagnostic services;" (9) "Antimicrobial resistance control and laboratory systems;" and (10) "Integrated laboratory systems' contributions to disease control programmes." DISCUSSION: Following the technical presentations, thematic exchanges were planned around six key areas, with one country presenting their experiences per theme, both at the meeting held in French and for the meeting held in English. Therefore, two countries' experiences are detailed around each of the six thematic areas, which are: laboratory governance (Guinea and Sierra Leone), laboratory policy and planning (Togo and Zimbabwe), regulation and legislation (Senegal and Ghana), partnerships (the Democratic Republic of the Congo and Nigeria), management of laboratory technology (Gabon and Zambia), and national laboratory networks (Burkina Faso and Rwanda).

conclusionThrough these meetings, laboratory leaders were able to not only learn from best practices and anticipate challenges for their own respective countries, but also benefit from joining a platform for laboratory leaders to foster cross-country connections for the duration of their careers. Ultimately, these meetings signal the beginning of many fruitful collaborations and opportunities in the African Region in laboratory and diagnostic services.

Indexed as

AfricaDiagnostic and laboratory servicesGlobal healthHealth governanceHealth systemsMultisectoral actionPrimary health carePublic administrationPublic policySustainable Development GoalsUniversal Health CoverageWorld Health Organization

Identifiers

PMID39605011
PMCPMC11603677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.